project id: TCGA-SKCM; case submitter id: TCGA-EB-A3Y7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.6; age at index: 86; days to birth: -31622; days to death: 326; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1926; age at diagnosis: 31622; ajcc pathologic m: M0; ajcc pathologic n: N2c; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 0.0; icd 10 code: C49.0; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of head, face, and neck; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 111; days to sample procurement: 0; initial weight: 460.0; portion submitter id: TCGA-EB-A3Y7-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 30.0; percent stromal cells: 5.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0;